Related Experiment Video

Updated: Mar 12, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Home-based vs inpatient education for children newly diagnosed with type 1 diabetes

H Clapin1,2, L Hop1, E Ritchie1

  • 1Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Australia.

Pediatric Diabetes
|November 4, 2016
PubMed

Insights

Newly diagnosed children with type 1 diabetes (T1D) can be safely managed at home with practical skills training and adequate support, reducing hospital stays without compromising outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Healthcare Delivery Models

Background:

  • Management of new-onset type 1 diabetes (T1D) in children varies globally.
  • Limited high-quality evidence exists on the effectiveness of different care models for pediatric T1D.

Purpose of the Study:

  • To compare a traditional inpatient model with a hybrid home-based approach for newly diagnosed pediatric T1D.
  • To evaluate metabolic, psychosocial outcomes, diabetes knowledge, length of hospital stay, and patient satisfaction.

Main Methods:

  • Randomized-controlled trial involving children aged 3-16 years with newly diagnosed T1D.
  • Comparison of a 5-6 day inpatient stay versus a 2-day stay with subsequent home-based management and multidisciplinary team support.
  • Assessment of clinical outcomes (HbA1c, hypoglycemia, readmissions) and patient-reported outcomes over 12 months.

Main Results:

  • No significant differences were observed in medical or psychosocial outcomes, or diabetes knowledge between the groups.
  • The home-based management group experienced a shorter average hospital stay by 1.9 days.
  • A majority of families preferred home-based management in retrospect.

Conclusions:

  • Home-based management is a safe and effective alternative for newly diagnosed pediatric T1D patients.
  • Adequate practical skills training and support are crucial for successful home-based T1D management.
  • This model offers potential benefits in terms of reduced hospital length of stay and patient satisfaction.
Abstract

Keywords:
ambulatoryeducationpediatricrandomized-controlled trialtype 1 diabetes mellitus

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

66.3K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K